Resmed's Q2 Earnings on Deck: What's in Store for the Stock? [Yahoo! Finance]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Yahoo! Finance
The renowned sleep health device maker posted adjusted earnings per share (EPS) of $2.55 in the last reported quarter, which surpassed the Zacks Consensus Estimate by 2.41%. The company topped earnings estimates in each of the trailing four quarters, the average surprise being 3.04%. For the second quarter of fiscal 2026, the Zacks Consensus Estimate for Resmed's revenues is pegged at $1.39 billion, indicating an increase of 8.3% from the year-ago reported figure. The Zacks Consensus Estimate for the company's second-quarter fiscal 2026 EPS suggests a 10.3% rise to $2.68. Estimates for Resmed's fiscal second-quarter earnings have remained stable in the past 60 days. Here's a brief review of the company's performance leading up to this announcement. Within this segment, Resmed is likely to have benefited from strong demand for its mask portfolio across the United States, Canada and Latin America regions. Growth may have also accelerated in Europe, Asia and the rest of the wo
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge [Yahoo! Finance]Yahoo! Finance
- ResMed Inc. (RMD): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell [Seeking Alpha]Seeking Alpha
- ResMed (NYSE:RMD) had its price target raised by analysts at Wells Fargo & Company from $265.00 to $270.00. They now have an "equal weight" rating on the stock.MarketBeat
RMD
Earnings
- 1/29/26 - Beat
RMD
Sec Filings
- 2/9/26 - Form 144
- 2/6/26 - Form 4
- 2/6/26 - Form 4
- RMD's page on the SEC website